Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Lantheus Holdings Inc., 3 years.
Lantheus Holdings Inc.
Director
Ironwood Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +63,481 | — | — |
| Jun 16, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −21,571 | $3.73 | $80,460 |
| May 14, 2026 | Lantheus Holdings Inc. | Grant or award | +4,137 | — | — |
| Jun 10, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Jun 9, 2025 | Lantheus Holdings Inc. | Open-market sale | −5,192 | $81.62 | $423,771 |
| May 14, 2025 | Lantheus Holdings Inc. | Grant or award | +2,537 | — | — |
| Jun 18, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +24,311 | — | — |
| Jun 10, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −22,766 | $6.29 | $143,198 |
| May 28, 2024 | Lantheus Holdings Inc. | Open-market sale | −2,500 | $78.50 | $196,250 |
| May 9, 2024 | Lantheus Holdings Inc. | Grant or award | +2,635 | — | — |
| Jun 20, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +22,350 | — | — |
| May 11, 2023 | Lantheus Holdings Inc. | Grant or award | +2,012 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.